Benefits of innovative treatment for women with fibromyalgia: a procedure to follow
Phase 4
- Conditions
- Fibromyalgia
- Registration Number
- RBR-45zfr4b
- Lead Sponsor
- niversidade Federal de Sergipe
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Data analysis completed
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Female; between 35 and 65 years old, previously diagnosed with fibromyalgia by an experienced anesthesiologist according to the criteria of the American College of Rheumatology, in the chronic pain outpatient clinic of the University Hospital of the Federal University of Sergipe.
Exclusion Criteria
Hypersensitivity to the tested drugs; Recent injury or trauma; diagnosis of epilepsy, psychiatric disorders,rheumatic disorders, moderate or severe neuromuscular disorders, hypothyroidism or hyperthyroidism, arthropathy, infectious disease, another chronic pain syndrome, neoplasms.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected pain ireduction, assessed using the visual analog scales (VAS) and Neuropathic Pain in 4 questions (DN4);;It is sought the reduction of oxidative stress levels assessed through the values of superoxide dismutase, catalase, malondealdehyde and Iron reduction power (FRAP)
- Secondary Outcome Measures
Name Time Method It is expected a gradual reduction in pain intensity with maintenance of the effect even after two weeks fromlast intervention. This variable was assessed using the visual pain scale (VAS) and Neuropathic Pain in 4 questions (DN4)